Title |
The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth
|
---|---|
Published in |
Cancer Immunology, Immunotherapy, October 2018
|
DOI | 10.1007/s00262-018-2262-5 |
Pubmed ID | |
Authors |
Tyler R. McCaw, Mei Li, Dmytro Starenki, Sara J. Cooper, Mingyong Liu, Selene Meza-Perez, Rebecca C. Arend, Donald J. Buchsbaum, Andres Forero, Troy D. Randall |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 42 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 8 | 19% |
Student > Master | 5 | 12% |
Other | 3 | 7% |
Professor | 3 | 7% |
Student > Doctoral Student | 2 | 5% |
Other | 5 | 12% |
Unknown | 16 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Immunology and Microbiology | 10 | 24% |
Biochemistry, Genetics and Molecular Biology | 6 | 14% |
Medicine and Dentistry | 6 | 14% |
Psychology | 1 | 2% |
Business, Management and Accounting | 1 | 2% |
Other | 0 | 0% |
Unknown | 18 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 February 2019.
All research outputs
#15,207,446
of 24,143,470 outputs
Outputs from Cancer Immunology, Immunotherapy
#2,060
of 2,880 outputs
Outputs of similar age
#197,790
of 352,573 outputs
Outputs of similar age from Cancer Immunology, Immunotherapy
#17
of 24 outputs
Altmetric has tracked 24,143,470 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,880 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 352,573 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 24 others from the same source and published within six weeks on either side of this one. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.